Summary & Overview
HCPCS Level II J2271: Injection, Morphine Sulfate 100mg
HCPCS Level II code J2271 denotes an injection of morphine sulfate, 100 mg, a commonly used parenteral opioid for acute and severe pain management. Nationally, this code is relevant across inpatient, emergency, and ambulatory settings where injectable analgesia is administered and is subject to payer coverage policies, prior authorization rules, and opioid stewardship programs.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, payer coverage considerations, and clinical contexts in which J2271 is typically used. The publication summarizes billing and reimbursement benchmarks, common utilization settings, and policy updates that affect how injectable opioids are billed and reimbursed. It also outlines documentation elements typically required by payers and highlights relationships to clinical practice such as acute pain management and perioperative analgesia.
This executive summary serves clinicians, billing professionals, and policy analysts seeking a national-level reference on coding, coverage context, and the operational considerations associated with HCPCS Level II code J2271.
Billing Code Overview
HCPCS Level II code J2271 represents an injection of morphine sulfate, 100 mg. This code corresponds to a parenteral opioid analgesic formulation intended for administration by a qualified clinician.
Service Type: Injectable opioid analgesic administration
Typical Site of Service: Hospital inpatient or outpatient settings, emergency department, ambulatory surgical centers, and other clinical settings where parenteral analgesia is provided
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department or inpatient unit with acute severe pain from trauma, postoperative pain not controlled by oral opioids, or advanced cancer pain requiring parenteral opioid administration. The provider (emergency physician, hospitalist, anesthesiologist, or palliative care physician) orders J2271 for intravenous or intramuscular administration of morphine sulfate, 100 mg vial/dose, when a higher-potency parenteral opioid is clinically indicated. The clinical workflow includes assessment of pain intensity, review of allergies and opioid tolerance, documentation of baseline respiratory status and sedation level, consent when appropriate, preparation and verification of the medication dose by nursing or pharmacy, administration with appropriate monitoring (respiratory rate, oxygen saturation, blood pressure), and post-administration reassessment. For hospitalized patients, the administration is recorded in the medication administration record and linked to the billed J2271 HCPCS code for outpatient or facility billing scenarios where injectable drugs are reportable. Typical settings include emergency department, inpatient hospital, observation unit, ambulatory surgery center, and hospice or palliative care inpatient units.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |